Advances in the Molecular Morphology of Hematopathology

Wang SA , Wang L , Hochberg EP . Low histologic grade follicular lymphoma with high proliferation index: morphologic and clinical features. Am J Surg Pathol. 2005; 29: 1490–1496.

Koster A , Tromp HA , Raemaekers JM . The prognostic significance of the intra-follicular tumor cell proliferative rate in follicular lymphoma. Haematologica. 2007; 92: 184–190.

Martinez AE , Lin L , Dunphy CH . Grading of follicular lymphoma: comparison of routine histology with immunohistochemistry. Arch Pathol Lab Med. 2007; 131: 1084–1088.

Harris NL , Swerdlow SH , Jaffe ES . Follicular lymphoma. In: Swerdlow SH , Campo E , Harris NL , eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008: 220–226.

Determann O , Hoster E , Ott G , et al; European Mantle Cell Lymphoma Network and the German Low Grade Lymphoma Study Group. Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group. Blood. 2008; 111: 2385–2387.

Garcia M , Romaguera JE , Inamdar KV , Rassidakis GZ , Medeiros LJ . Proliferation predicts failure-free survival in mantle cell lymphoma patients treated with ritux-imab plus hyperfractionated ciclophosphamide, vincris-tine, doxorubicin, and dexamethasone alternating with rituximab plus high-dose methotrexate and cytarabine. Cancer. 2009; 111: 1041–1048.

Hsi ED , Jung SH , Lai R . Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study. Leuk. Lymphoma. 2008; 49: 2081–2090.

Kanungo A , Medeiros LJ , Abruzzo LV , Lin P . Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis. Mod Pathol. 2006; 19: 25–33.

Klapper W , Stoecklein H , Zeynalova S , et al; German High-Grade Non-Hodgkin's Lymphoma Study Group. Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). Leukemia. 2008; 22: 2226–2229.

Johnson NA , Savage KJ , Ludkovski O . Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. Blood. 2009; 114: 2273–2279.

Yoon SO , Jeon YK , Paik JH . MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type. Histopathology. 2008; 53: 205–217.

Le Gouill S , Talmant P , Touzeau C . The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement. Haematologica. 2007; 92: 1335–1342.

Lin P , Medeiros LJ . High-grade B-cell lymphoma/leukemia associated with t(14;18) and 8q24/MYC rearrangement: a neoplasm of germinal center immunophenotype with poor prognosis. Haematologica. 2007; 92: 1297–1301.

Cerroni L , Massone C , Kutzner H , Mentzel T , Umbert P , Kerl H . Intravascular large T-cell or NK-cell lymphoma: a rare variant of intravascular large cell lymphoma with frequent cytotoxic phenotype and association with Epstein-Barr virus infection. Am J Surg Pathol. 2008; 32: 891–898.

Dorfman DM , Brown JA , Shahsafaei A , Freeman GJ . Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma. Am J Surg Pathol. 2006; 30: 802–810.

Dupuis J , Boye K , Martin N . Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL). A new diagnostic marker providing evidence that AITL derives from follicular helper T cells. Am J Surg Pathol. 2006; 30: 490–494.

Grogg KL , Attygalle AD , Macon WR , Remstein ED , Kurtin PJ , Dogan A . Expression of CXCL13, a chemo-kine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified. Mod Pathol. 2006; 19: 1101–1107.

Nam-Cha SH , Roncador G , Sanchez-Verde L . PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma. Am J Surg Pathol. 2008; 32: 1252–1257.

Carreras J , Lopez-Guillermo A , Roncador G . High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma. J Clin Oncol. 2009; 27: 1470–1476.

Vermi W , Lonardi S , Bosisio D . Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma. J Pathol. 2008; 216: 356–364.

Rossi S , Laurino L , Furlanetto A . Rabbit monoclonal antibodies: a comparative study between a novel category of immunoreagents and the corresponding mouse monoclonal antibodies. Am J Clin Pathol. 2005; 124: 295–302.

Torlakovic E , Nielsen S , Vyberg M . Antibody selection in immunohistochemical detection of cyclin D1 in mantle cell lymphoma. Am J Clin Pathol. 2005; 124: 782–789.

Mozos A , Royo C , Hartmann E . SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica. 2009; 94: 1555–1562.

Dictor M , Ek S , Sundberg M . Strong lymphoid nuclear expression of SOX11 transcription factor defines lympho-blastic neoplasms, mantle cell lymphoma and Burkitt's lym-phoma. Haematologica. 2009; 94: 1563–1568.

Soulier J , Grollet L , Oksenhendler E . Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood. 1995; 86: 1276–1280.

Dupin N , Diss TL , Kellam P . HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood. 2000; 95: 1406–1412.

Carbone A , Gloghini A . KSHV/HHV8-associated lymphomas. Br J Haematol. 2008; 140: 13–24.

Du MQ , Diss TC , Liu H . KSHV- and EBV-associated germinotropic lymphoproliferative disorder. Blood. 2000; 100: 3415–3418.

Amin HM , Medeiros LJ , Yaziji H , Gown AM . Dissolution of the lymphoid follicle is a feature of the HHV8+ variant of plasma cell Castleman's disease. Am J Surg Pathol. 2003; 27: 91–100.

Facchetti F , Jones DM , Petrella T . Blastic plasmacytoid dendritic cell neoplasm. In: Swerdlow SH , Campo E , Harris NL , eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008: 145–147.

Jegalian AG , Facchetti F , Jaffe ES . Plasmacytoid dendritic cells: physiologic roles and pathologic states. Adv Anat Pathol. 2009; 16: 392–404.

Petrella T , Bagot M , Willemze R . Blastic NK-cell lymphomas (agranular CD4+ CD56+ hematodermic neoplasms): a review. Am J Clin Pathol. 2005; 123: 662–675.

Petrella T , Comeau MR , Maynadie M . “Agranular CD4+ CD56+ hematodermic neoplasm” (blastic NK-cell lymhoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol. 2002; 26: 852–862.

Marafioti T , Paterson JC , Ballabio E . Novel markers of normal and neoplastic human plasmacytoid dendritic cells. Blood. 2008; 111: 3778–3792.

Dzionek A , Sohma Y , Nagafune J . BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lec-tin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med. 2001; 194: 1823–1834.